Navigation Links
Dispelling Myths of Root Canals Through Education
Date:3/24/2011

CHICAGO, March 24, 2011 /PRNewswire/ -- When it comes to their teeth, Americans have strong feelings about keeping them. According to a January 2011 survey by the American Association of Endodontists, 70 percent of Americans want to avoid losing their natural teeth. One way to help people maintain their natural teeth is through root canal treatment. During Root Canal Awareness Week, March 27 – April 2, the American Association of Endodontists wants to dispel the negative myths surrounding this dental treatment and encourage patients who need a root canal to see an endodontist who will skillfully provide this treatment.

"Nothing looks, feels or functions as well as your natural teeth. Choosing to save a tooth with root canal treatment will help you sustain your ability to bite and chew and maintain the natural appearance of your smile," said AAE President Dr. Clara M. Spatafore.

More than 15 million root canals are performed each year in the U.S., and the vast majority of root canal patients - 89 percent – say they were satisfied when they received treatment from an endodontist, a dentist who specializes in root canals. And yet 70 percent of U.S. respondents in the AAE's recent survey also said they feared having a root canal.  

"Ironically, when patients have an infected tooth, a root canal is the very procedure that can save it," said Dr. Spatafore. "Many patients do not realize that, just like any other medical specialty, significant advances in technology have enabled endodontists to perform root canals safely and comfortably."

Endodontists are dentists who have completed at least two additional years of American Dental Association-approved advanced specialty education and training in the diagnosis and treatment of tooth pain. Their practice is focused on preserving natural teeth, mostly through performing root canal treatment.

AAE research shows that patients who have experienced root canal treatment are si
'/>"/>

SOURCE American Association of Endodontists
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Survey Reveals Majority of Americans Hold onto Myths About What Causes Colds and How to Treat Them
2. Durable Medical Equipment Community Supports Tough Anti-Fraud Measures, Corrects Persistent Myths
3. Discussion of Medicares Competitive Bidding Program for Home Medical Equipment is Plagued by Myths and Misinformation
4. The Anatomy of Clinical Trials: Greys Season Finale Leaves Public in the Dark About the Myths and Realities
5. Detroit Medical Center Is First in Michigan to Offer New Breakthrough Technology for Correcting Irregular Heartbeat
6. International Biotech Firm Funds Research Into Aging Through Foundation of UMDNJ
7. Nephros Announces Completion of $3.2 Million Financing Through Rights Offering and Private Placement Transactions
8. FDA Approves BENLYSTA® for Lupus in Breakthrough for Millions of Sufferers
9. Nephros Announces $3.2 Million Financing Through Completion of Rights Offering and Private Placement Transactions
10. Health Diagnostic Laboratory, Inc. (HDL, Inc.) Partners With Gamma Therapeutics to Offer Breakthrough Diagnostic Assay for Heart Attack and Stroke Risk
11. Kidz-Med VeraTemp Expected in Pharmacies throughout Canada by Fall 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... -- ResMed (NYSE: RMD ) has introduced the ... the United States . The Astral platform is ... support ventilators. ResMed,s new Astral life ... for patients suffering from neuromuscular disease, chronic obstructive pulmonary ... The U.S. launch comes on the heels of Astral,s ...
(Date:9/2/2014)... 2014   Mast Therapeutics, Inc . (NYSE MKT: MSTX) today ... , will present at the Rodman and Renshaw 16 th ... p.m. Eastern time in the Holmes II Salon at The New ... Interested parties can access a live audio webcast and ... . An archived presentation will be available on the web site ...
(Date:9/2/2014)... Sept. 2, 2014  BioSpecifics Technologies Corp. (NASDAQ: ... products marketed as XIAFLEX ® in the U.S. and ... President, Tom Wegman , will present at the following ... Rodman & Renshaw 16 th Annual ... Tuesday, September 9, 2014 at 9:10 a.m. EDT ...
Breaking Medicine Technology:ResMed's Revolutionary Life Support Ventilation Platform -- Astral 100 and 150 Devices Now Available in the U.S. 2ResMed's Revolutionary Life Support Ventilation Platform -- Astral 100 and 150 Devices Now Available in the U.S. 3Mast Therapeutics To Present At The Rodman And Renshaw 16th Annual Global Investment Conference On September 9th 2Mast Therapeutics To Present At The Rodman And Renshaw 16th Annual Global Investment Conference On September 9th 3BioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences 2
... SEATTLE, Jan. 13, 2011 Dendreon Corporation (Nasdaq: ... market and other conditions, $500 million aggregate principal amount of ... an offering registered under the Securities Act of 1933, as ... cash, shares of Dendreon,s common stock (the "Common Stock") or ...
... BURLINGAME, Calif., Jan. 13, 2011 Collaborative Drug Discovery, Inc. ... has extended its previous grant to CDD to create a ... drugs against tuberculosis (TB). The TB bacillus infects approximately one ... 1.5 million people every year. Over the past ...
Cached Medicine Technology:Dendreon Announces Offering of $500 Million Convertible Senior Notes Due 2016 2Dendreon Announces Offering of $500 Million Convertible Senior Notes Due 2016 3Dendreon Announces Offering of $500 Million Convertible Senior Notes Due 2016 4Collaborative Drug Discovery Receives New Funding to Support Tuberculosis Drug Discovery Screening Efforts and Industrial-Academic Collaborations 2
(Date:9/2/2014)... 2014 USARAD Holdings Inc. a ... solutions provider, including SecondOpinions.com® – consumer division is ... advanced services. The telemedicine industry pioneer is now ... , Founded and established in 1963 as the ... began as a maternity care hospital with very ...
(Date:9/2/2014)... to announce that the following papers will be ... Congress 2014, taking place in Barcelona, Spain, 30 ... strut biodegradable polymer sirolimus-eluting stent versus durable polymer ... randomised, single-blind, non-inferiority trial, Windecker et al ... surface polymer, and drug release have improved clinical ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 The global ... USD 8,918.8 million by 2020, growing at an estimated ... a new study by Grand View Research, Inc. Peripheral ... plague modification devices are used for treating peripheral arterial ... of atherosclerotic plaques in arteries. These devices are used ...
(Date:9/2/2014)... Denver, Colo. (PRWEB) September 02, 2014 ... reimagined patient care, has been selected from a group ... round of the 2014 PrIME Digital Health Challenge. The ... against one another, Tuesday, Sept. 9th at the CSU ... in 2012, MyRounding is based in Denver, Colo. The ...
(Date:9/2/2014)... Headaches, both chronic and acute ruin lives. They can ... friends, sleeping and just coping well with daily activities. ... worldwide. The medications prescribed for these conditions frequently don’t ... cases of headache and back pain are of a mechanical ... detect and fix the cause. , When a sports ...
Breaking Medicine News(10 mins):Health News:USARAD Holdings Inc. SECONDOPINIONS.COM® Partners With Prestigious Dar Al Shifa Hospital In Kuwait 2Health News:USARAD Holdings Inc. SECONDOPINIONS.COM® Partners With Prestigious Dar Al Shifa Hospital In Kuwait 3Health News:USARAD Holdings Inc. SECONDOPINIONS.COM® Partners With Prestigious Dar Al Shifa Hospital In Kuwait 4Health News:The Lancet: European Society of Cardiology Congress 2014 media alert 2Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 2Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 3Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 4Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 5Health News:MyRounding Selected for Digital Health Venture Showcase Finals Top Three Startups Awarded $50,000 2Health News:Physical Therapists in Houston Learn Pain Relief Techniques 2
... you,re ready to drive again , , WEDNESDAY, Dec. 10 (HealthDay ... wheel again after orthopedic surgery or injury, but knowing when it,s ... , Orthopedic surgeons weigh in on the issue in the December ... , "Deciding when a patient can return to driving is ...
... (OTC Pink Sheets: SNDY ) is pleased to announce that ... by over 10% compared to the same time period for 2007. ... $28,509 for the same month last year. This marks the second ... of October. , , The Mammo ...
... Inc., a leading,provider of software and databases for systems ... Singapore Immunology Network (SIgN) has become a,certified GeneGo Center ... MetaCore, training and advanced support. SIgN COE will ... "We are excited ...
... Facilities , , NEW ... process, a proven commitment to clinical quality earned SigmaCare(R) ... Metropolitan Jewish Health System,s (Metropolitan) skilled nursing facilities. ... nationally recognized nonprofit organization, operates Metropolitan Jewish Geriatric Center, ...
... Pharma Services, Goodwill, , , ... NYSE: MDZ ), a leading provider of products and ... fiscal 2008 performance. , Based on preliminary information, MDS ... of $1,210 million to $1,220 million and adjusted EBITDA in the ...
... Care Insurance While They,re Still Healthy Enough to Qualify , ... If you,ve put off getting long term care insurance, ... new administration,s health plan? "I wouldn,t advise it," says Denise ... (LTCFP), one of the nation,s most experienced long term care ...
Cached Medicine News:Health News:Returning to the Road Tricky After Injury 2Health News:Solos Endoscopy, Inc. Increases Sales Revenue for October 2008 by Over 10% as Compared to Last Year 2Health News:A*STAR's Singapore Immunology Network Is the First GeneGo Center of Excellence in Asia 2Health News:Metropolitan Jewish Health System Awards Electronic Medical Records Contract to SigmaCare(R) 2Health News:Metropolitan Jewish Health System Awards Electronic Medical Records Contract to SigmaCare(R) 3Health News:MDS Provides Update on Fiscal 2008 Performance 2Health News:MDS Provides Update on Fiscal 2008 Performance 3Health News:MDS Provides Update on Fiscal 2008 Performance 4Health News:Obama Health Plan Not Likely to Embrace Long Term Care, Industry Leader Says 2
The Vitatron Excellence S+ lead series are endocardial leads providing excellent reliability and optimal pacing characteristics....
... II lead series are silicon rubber ... the longevity of the pacemaker system ... high impedance of the lead as ... surface, combined with the elution of ...
CapSure SP endocardial tined pacing leads combine the steroid-eluting technology of the CapSure generation of leads with the platinization technology of Target Tip leads, to provide stable, low pacin...
Selute Picotip Atrial-J steroid eluting passive fixation lead...
Medicine Products: